milrinone has been researched along with amiodarone in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Astley, N; Bonner, FW; Eason, CT; Pattison, A | 1 |
Bush, DM; Cohen, MI; Gaynor, JW; Hoffman, TM; Rhodes, LA; Spray, TL; Wernovsky, G; Wieand, TS | 1 |
Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
Brocks, DR; Elsherbiny, ME; Gabr, RQ; Pollak, PT; Somayaji, V | 1 |
1 review(s) available for milrinone and amiodarone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for milrinone and amiodarone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood.
Topics: Adenosine Diphosphate; Amiodarone; Arachidonic Acid; Arachidonic Acids; Cardiotonic Agents; Collagen; Fibrinolytic Agents; Humans; Male; Milrinone; Naphthyridines; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridazines; Pyridones | 1990 |
Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment.
Topics: Amiodarone; Cardiac Pacing, Artificial; Child; Child, Preschool; Dopamine; Female; Heart Defects, Congenital; Humans; Hypothermia, Induced; Incidence; Infant; Infant, Newborn; Male; Milrinone; Postoperative Care; Postoperative Complications; Risk Factors; Tachycardia, Ectopic Junctional | 2002 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone.
Topics: Amiodarone; Cardiovascular Diseases; Chromatography, Reverse-Phase; Cotinine; Humans; Liquid-Liquid Extraction; Mass Spectrometry; Milrinone; Nicotine; Reproducibility of Results; Tobacco Smoke Pollution | 2011 |